Onesource Specialty Pharma Limited — M&A Activity 2026

May 13, 2026

onesource

Corporate Office:
Star 1, Opp IIM Bangalore, Bilekahalli,
Bannerghatta Road, Bengaluru –
560076, India
T: +91 80 6784 0738

Registered Office:
Cyber One, Unit No. 902, Sector 30A,
Plot No - 4 & 6, Vashi,
Navi Mumbai - 400703, India
T: +91 22 2789 2924

Date: May 13, 2026

| BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai- 400001
Scrip Code: 544292 | National Stock Exchange of India Limited
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex,
Bandra (E), Mumbai – 400 051
Symbol: ONESOURCE |
| --- | --- |

Dear Sir/Madam,

Subject: Update on Composite Scheme of Arrangement and Amalgamation (Merger by Absorption) amongst Steriscience Specialties Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, Strides Pharma Services Private Limited and Onesource Specialty Pharma Limited and their respective shareholders (under section 230 to 232 read with section 234, section 52, section 66 of the Indian Companies Act and under section 210 read with section 212 of The Singapore Companies Act, 1967 and other applicable provisions of the Indian Companies Act, 2013, the Singapore Companies Act, 1967 and the rules framed thereunder (“Proposed Scheme”)

This is further to the earlier intimation on February 26, 2026, that the Company has received in-principle approval for the proposed scheme of arrangement relating to acquisition of the facilities of SteriScience (Poland and Baroda) into OneSource.

The Board of Directors at their meeting held today deliberated the proposed transaction and in the best interest of all stakeholders decided to not pursue the transaction in the current form and revisit it following successful delivery of respective companies’ FY28 guidance.

You are requested to kindly take the same in record.

For Onesource Specialty Pharma Limited

Trisha A
Digitally signed by
Trisha A
Date: 2026.05.13
13:20:38 +05'30'

Trisha A
Compliance Officer and Company Secretary
Membership Number: A47635

OneSource Specialty Pharma Limited
info@onesourcecdmo.com | www.onesourcecdmo.com
CIN: L74140MH2007PLC432497